New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer
11 Jun 2010
New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer
Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma
The role of genetic mutations in lung cancer
The use of monoclonal antibodies to treat mesothelioma
Tumour circulating cells
The use of targeted radiotherapy to treat lung cancer
Asbestos related diseases
Personalised treatment for lung cancer
Lung cancer treatment: new drugs and possibilities
The future of lung cancer treatment
Advances in the treatment of lung cancer
Breast cancer stem cells